| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |